Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 5.8d

Adjusted Graft Survival, Living Donor Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2005 - 2006) (Tx 2005 - 2006) (Tx 2001 - 2006) (Tx 1996 - 2006)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 12,995 97.7% 0.1% 12,995 95.7% 0.2% 38,331 80.8% 0.3% 60,494 57.9% 0.4%
Primary Diagnosis Glomerular Diseases 3,842 97.8% 0.2% 3,842 95.8% 0.3% 11,544 82.2% 0.5% 18,825 63.4% 0.7%
Diabetes 2,708 97.9% 0.3% 2,708 95.1% 0.4% 8,094 76.5% 0.7% 12,613 45.9% 1.0%
Hypertensive Nephrosclerosis 1,927 97.3% 0.4% 1,927 95.5% 0.5% 4,971 78.4% 0.9% 7,343 50.9% 1.4%
Polycystic Kidneys 1,380 97.9% 0.4% 1,380 96.6% 0.5% 3,832 88.7% 0.7% 5,522 71.8% 1.5%
Tubular and Interstitial Diseases 814 97.7% 0.5% 814 96.2% 0.7% 2,550 80.6% 1.1% 4,311 59.7% 1.4%
Renovascular & Other Vascular Diseases 315 97.8% 0.8% 315 96.2% 1.1% 1,271 79.6% 1.5% 2,088 47.8% 2.4%
Congenital, Rare Familial, & Metabolic Disorders 520 97.3% 0.7% 520 95.6% 1.0% 1,642 82.5% 1.4% 2,644 64.8% 1.9%
Neoplasms 57 96.5% 2.4% 57 93.1% 3.3% 174 81.3% 4.0% 259 55.4% 7.2%
Other 1,300 97.1% 0.5% 1,300 95.1% 0.6% 3,651 80.4% 0.9% 5,837 60.4% 1.3%
Unknown 132 98.5% 1.1% 132 96.2% 1.7% 602 79.0% 2.1% 1,052 55.7% 3.5%


Source: OPTN/SRTR Data as of May 1, 2008.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.



PDF FormatRequires Adobe Acrobat Reader